Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Alkylating agents prostate cancer

Both estramustine combined with vinblastine and mitoxantrone combined with prednisone are active combination regimens for refractory prostate cancer. Although estramustine as a single agent produced similar response rates to other available chemotherapy agents, development of estramustine combinations (such as estramustine plus vinblastine or estramustine plus docetaxel) continued when its mechanism of action was discovered to involve microtubule proteins rather than alkylation. ... [Pg.2433]

See other pages where Alkylating agents prostate cancer is mentioned: [Pg.278]    [Pg.170]    [Pg.582]    [Pg.281]    [Pg.79]    [Pg.143]    [Pg.437]    [Pg.800]    [Pg.205]    [Pg.114]    [Pg.2302]    [Pg.248]    [Pg.248]    [Pg.898]    [Pg.437]    [Pg.813]    [Pg.276]    [Pg.208]   
See also in sourсe #XX -- [ Pg.707 ]



SEARCH



Alkylating agents alkylation

Alkylation agents

Cancer agents

Cancer alkylating agents

Cancer, prostat

Prostate cancer

Prostatic cancer

© 2024 chempedia.info